This is the authors' abstract. We don't add key points for this paper.
Treatment with I.C.R.F. 159 completely inhibited metastasis formation in mice implanted with Lewis lung carcinoma at doses having little influence on the rate of growth of the primary implant. This inhibition was due to the effect of I.C.R.F. 159 on the development of blood vessels of the invading margins of the primary tumour. So far as is known, this is the first time a drug has induced a specific loss of the malignant characteristic of blood-borne tumour cell dissemination.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Salsbury et al. (1970) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: